LEU - Overview: Fecal Leukocytes, Feces
Suggesting the presence of pathogens such as Salmonella, Shigella, and amebiasis
PBOU - Overview: Lead Occupational Exposure, Random, Urine
Detecting clinically significant lead exposure due to occupational exposure in random urine specimens This test is not a substitute for blood lead screening.
SEWB - Overview: Selenium, Blood
Assessment of tissue stores of selenium
FSCPR - Overview: Scleroderma Comprehensive Profile
Scleroderma Comprehensive Profile
RT3 - Overview: T3 (Triiodothyronine), Reverse, Serum
Aiding in the diagnosis of the sick euthyroid syndrome
WBGDD - Overview: Beta-Globin Gene Cluster, Deletion/Duplication, Varies
Determining the etiology of hereditary persistence of fetal hemoglobin (HPFH), delta-beta thalassemia, or other large deletions involving the beta-globin gene cluster Diagnosing less common causes of beta thalassemia; these large...
ADNA1 - Overview: Double-Stranded DNA (dsDNA) Antibodies, IgG, Serum
Evaluating patients with clinical features or at-risk for systemic lupus erythematosus (SLE) Monitoring disease activity, as an adjunct test, in patients with SLE previously positive for double-stranded DNA IgG antibodies
LYWB - Overview: Lyme Disease Antibody, Immunoblot, Serum
Aiding in the diagnosis of systemic Lyme disease This test should not be used as a screening assay.
ABYSR - Overview: Antibody Screen with Reflexed Antibody Identification, Blood
Detection of allo- or autoantibodies directed against red blood cell antigens in the settings of pretransfusion testing Evaluation of transfusion reactions Evaluation of hemolytic anemia
CRP - Overview: C-Reactive Protein (CRP), Serum
Detecting systemic inflammatory processes Detecting infection and assessing response to antibiotic treatment of bacterial infections Differentiating between active and inactive disease forms with concurrent infection
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....